Study of SGC001 Injection for Predicted Severe Acute Pancreatitis to Assess Safety, Tolerability and Preliminary Efficacy | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study of SGC001 Injection for Predicted Severe Acute Pancreatitis to Assess Safety, Tolerability and Preliminary Efficacy	Digestive System Diseases, acute pancreatitis, pancreas disorder, pancreatitis	Not yet recruiting	Phase 2	2026-09-04		NCT07803965

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Beijing Sungen Biomedical Technology Co., Ltd	3

15 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
General Hospital of Northern Theater Command of the Chinese People's Liberation Army	Shenyang	China	1
General Hospital of the Eastern Theater Command of the Chinese People's Liberation Army	Nanjing	China	1
Li Huili Hospital, Ningbo Medical Center	Ningbo	China	1
Renmin Hospital of Wuhan University	Wuhan	China	18
Shanghai General Hospital	Shanghai	China	35
The Affiliated Hospital of Guizhou Medical University	Guizhou	China	3
The First Affiliated Hospital of Henan University of Science and Technology	Luoyang	China	13
The First Affiliated Hospital of Nanchang University	Nanchang	China	55
The First Affiliated Hospital of Xiamen University	Xiamen	China	40
The Second Affiliated Hospital of Anhui Medical University	Hefei	China	16
The Second Hospital of Hebei Medical University	Shijiazhuang	China	9
West China Hospital, Sichuan University	Chengdu	China	30
Zhejiang Provincial People's Hospital	Hangzhou	China	19
Zhongshan Hospital, Xiamen University	Xiamen	China	1
Zibo Central Hospital	Zibo	China	8